These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease. Vihinen MK; Kolho KL; Jänne OA; Andersson S; Raivio T J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):504-6. PubMed ID: 19322063 [TBL] [Abstract][Full Text] [Related]
13. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH]. Dejaco C; Haas T; Kirchgatterer A; Miehsler W; Wenzl H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W; Tilg H Z Gastroenterol; 2006 Jun; 44(6):525-38; discussion 539. PubMed ID: 16773519 [TBL] [Abstract][Full Text] [Related]
14. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Kolho KL; Raivio T; Lindahl H; Savilahti E Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972 [TBL] [Abstract][Full Text] [Related]
15. IL-6 may modulate the skeletal response to glucocorticoids during exacerbations of inflammatory bowel disease. Kriel M; Sayers A; Fraser WD; Williams AM; Koch A; Zacharowski K; Probert CS; Tobias JH Calcif Tissue Int; 2010 May; 86(5):375-81. PubMed ID: 20229252 [TBL] [Abstract][Full Text] [Related]
16. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related]
17. The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy. Szabó V; Borgulya G; Filkorn T; Majnik J; Bányász I; Nagy ZZ Mol Vis; 2007 Apr; 13():659-66. PubMed ID: 17563720 [TBL] [Abstract][Full Text] [Related]
18. Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. De Iudicibus S; Stocco G; Martelossi S; Drigo I; Norbedo S; Lionetti P; Pozzi E; Barabino A; Decorti G; Bartoli F; Ventura A Gut; 2007 Sep; 56(9):1319-20. PubMed ID: 17698869 [No Abstract] [Full Text] [Related]
19. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. Adcock IM; Lane SJ; Brown CR; Peters MJ; Lee TH; Barnes PJ J Immunol; 1995 Apr; 154(7):3500-5. PubMed ID: 7897230 [TBL] [Abstract][Full Text] [Related]
20. Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease. Vihinen MK; Raivio T; Verkasalo M; Jänne OA; Kolho KL J Clin Gastroenterol; 2008 Oct; 42(9):1017-24. PubMed ID: 18496232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]